EPO considers biotech questions
Caroline Pallard and Dorothea Mayer of Nederlandsch Octrooibureau assess the implications of recent developments in European biotech case law
Recent European case law has addressed the exclusion of essential biological processes applied to plants, the exclusion of diagnostic methods and the industrial applicability of a nucleic acid sequence.
Essentially biological processes
A plant variety could fall under a European patent...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.